Search Within

John Mendelsohn

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
  3. Conference Paper (1)
Groups
  1. Department of Medicine (6)
  2. Genitourinary Oncology Service (6)
  3. Solid Tumor Oncology Division (6)
  4. GSK Faculty (2)
  5. Molecular Pharmacology and Chemistry Program Faculty (2)
  6. Sloan Kettering Institute Faculty (2)

More Groups

People
  1. Howard Scher (6)
  2. Tony DeBlasio (3)
  3. Zhen Fan (3)
  4. Alvaro Sarkis (1)
  5. Carlos Cordon-Cardo (1)
  6. George Netto (1)

More People

Years
  1. 1997 (1)
  2. 1996 (4)
  3. 1995 (1)
Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. Journal of Immunotherapy (1)
  5. Seminars in Oncology (1)
Publishers
  1. American Association for Cancer Research (4)
  2. Elsevier Inc. (1)
  3. Lippincott Williams & Wilkins (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Regulation of p21(WAF1/CIP1) transcription by epidermal growth factor in human squamous carcinoma cell line A431
    Meeting Abstract

    Peng, D.; Fan, Z.; Lu, Y.; Deblasio, T.; Scher, H.; Mendelsohn, J.
    Proceedings of the American Association for Cancer Research Annual Meeting (1997)

    Fulltext@MSK | Save
  • Blockade of epidermal growth factor receptor (EGFR) by anti-EGFR monoclonal antibody (mAb225) induces G1 arrest in prostatic cancer cell line DU145
    Meeting Abstract

    Peng, D.; Fan, Z.; Lu, Y.; DeBlasio, T.; Scher, H.; Mendelsohn, J.
    Proceedings of the American Association for Cancer Research Annual Meeting (1996)

    Fulltext@MSK | Save
  • Targeted therapy for prostate cancer: The Memorial Sloan-Kettering Cancer Center approach
    Conference Paper

    Slovin, S. F.; Livingston, P. O.; Rosen, N.; Sepp-Lorenzino, L.; Kelly, W. K.; Mendelsohn, J.; Scher, H. I.
    Elsevier Inc. (1996)

    Fulltext@MSK | Save
  • The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma
    Journal Article

    Prewett, M.; Rockwell, P.; Rockwell, R. F.; Giorgio, N. A.; Mendelsohn, J.; Scher, H. I.; Goldstein, N. I.
    Journal of Immunotherapy (1996)

    Fulltext@MSK | Save
  • Anti-epidermal growth factor receptor monoclonal antibody 225 up-regulates p27(KIP1) and induces G(1) arrest in prostatic cancer cell line DU145
    Journal Article

    Peng, D.; Fan, Z.; Lu, Y.; DeBlasio, T.; Scher, H.; Mendelsohn, J.
    Cancer Research (1996)

    Fulltext@MSK | Save
  • Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor α in the progression of prostatic neoplasms
    Journal Article

    Scher, H. I.; Sarkis, A.; Reuter, V.; Cohen, D.; Netto, G.; Petrylak, D.; Lianes, P.; Fuks, Z.; Mendelsohn, J.; Cordon-Cardo, C.
    Clinical Cancer Research (1995)

    Fulltext@MSK | Save